论文部分内容阅读
选取2013年2月~2014年7月收治的68例尿毒症患者。根据治疗方法的不同分为观察组和对照组各34例。观察组给予左卡尼汀配合血液透析治疗,对照组给予常规血液透析治疗。比较两组患者贫血改善情况、治疗前后血浆蛋白、红细胞比容增加情况。结果观察组治疗后红细胞比容增加为31.4±5.7%,高于对照组的25.2±4.1%;观察组治疗后血红蛋白为98.9±14.5g/L,高于对照组的81.2±12.9g/L;观察组治疗后贫血改善总有效率为94.12%,明显高于对照组的73.53%。左卡尼汀配合透析治疗尿毒症患者具有较好疗效,可增加血红蛋白含量,提高红细胞比容,改善贫血,值得临床应用并大力推广。
Sixty-eight uremic patients were selected from February 2013 to July 2014. According to the different treatment methods were divided into observation group and control group of 34 cases. The observation group was treated with levocarnitine and hemodialysis, while the control group was given conventional hemodialysis. Comparison of two groups of patients to improve anemia, plasma protein, hematocrit increase before and after treatment. Results After treatment, the hematocrit increased by 31.4 ± 5.7% in observation group and 25.2 ± 4.1% in control group. The hemoglobin in observation group was 98.9 ± 14.5g / L, which was higher than that in control group (81.2 ± 12.9g / L) The total effective rate of anemia in the observation group after treatment was 94.12%, which was significantly higher than 73.53% of the control group. L-carnitine with dialysis in patients with uremia has a good effect, can increase hemoglobin content, improve hematocrit, and improve anemia, it is worthy of clinical application and promotion.